Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19
Pathogens · 02.08.2023 · 12 (8) · 1007
DOI: 10.3390/pathogens12081007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 02.08.2023. Verfasst von Ignacio Sánchez-Moguel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM, DGAPA-UNAM postdoctoral fellowship.
Abstract (Originalsprache)
Virus-like particles (VLPs) comprise one or many structural components of virions, except their genetic material. Thus, VLPs keep their structural properties of cellular recognition while being non-infectious. VLPs of Parvovirus B19 (B19V) can be produced by the heterologous expression of their structural proteins VP1 and VP2 in bacteria. These proteins are purified under denaturing conditions, refolded, and assembled into VLPs. Moreover, chimeric forms of VP2 have been constructed to harbor peptides or functional proteins on the surface of the particles without dropping their competence to form VLPs, serving as presenting nanoparticles. The in-vitro assembly approach offers exciting possibilities for the composition of VLPs, as more than one chimeric form of VP2 can be included in the assembly stage, producing multifunctional VLPs. Here, the heterologous expression and in-vitro assembly of B19V structural proteins and their chimeras are reviewed. Considerations for the engineering of the structural proteins of B19V are also discussed. Finally, the construction of multifunctional VLPs and their future potential as innovative medical tools are examined.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Bioquímica, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
- Departamento de Alimentos y Biotecnología, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, Mexico.
ORCID-Profile: Ignacio Sánchez-Moguel, Ismael Bustos-Jaimes
Förderung
- Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica (PAPIIT), UNAM
- DGAPA-UNAM postdoctoral fellowship
Zitieren
APA
Sánchez-Moguel, I., Montiel, C., & Bustos-Jaimes, I. (2023). Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19. Pathogens, 12(8), 1007. https://doi.org/10.3390/pathogens12081007
Vancouver
Sánchez-Moguel I, Montiel C, Bustos-Jaimes I. Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19. Pathogens. 2023;12(8):1007. doi:10.3390/pathogens12081007
BibTeX
@article{SnchezMoguel2023,
author = {Sánchez-Moguel, Ignacio and Montiel, Carmina and Bustos-Jaimes, Ismael},
title = {Therapeutic Potential of Engineered Virus-like Particles of Parvovirus B19},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {8},
pages = {1007},
doi = {10.3390/pathogens12081007}
}
EUVIMED